AKTHELIA PHARMACEUTICALS
Akthelia is an emerging pharmaceutical company focused on the discovery and development of novel antimicrobial therapeutics, which enhance the body‘s innate microbial defences. The ever-increasing resistance to currently marketed antibiotics has led to a clear need for novel anti-infective agents that are active against drug resistant bacteria, opportunistic infections and acute infections of unknown causes. Akthelia has a diverse pipeline of products under development, targeting microbial ... infections. The current focus is on lung and gastrointestinal infections. In close collaboration with scientists at the Karolinska Institute in Stockholm and University of Iceland, evidence of new active ingredients and modes of action is being generated. The ensuing research is feeding the product pipeline and generating new product opportunities for further development.
AKTHELIA PHARMACEUTICALS
Industry:
Biotechnology Medical Pharmaceutical
Founded:
2001-12-01
Address:
Reykjavík, Gullbringusysla, Iceland
Country:
Iceland
Website Url:
http://www.aktheliapharma.com
Total Employee:
1+
Status:
Active
Contact:
(354)510-1800
Email Addresses:
[email protected]
Total Funding:
64 M ISK
Technology used in webpage:
Euro Icelandic Server Location
Similar Organizations
Faron Pharmaceuticals
Faron Pharmaceuticals is a biopharmaceutical company engaged in the biotechnology and medical research industry.
Eden Biologics
Eden Biologics is a biopharmaceutical company that develops biosimilars and accelerates the development programs for clients & partners.
NuChem Sciences
NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.
PhaseBio Pharmaceuticals
PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.
PIQUR Therapeutics
PIQUR Therapeutics is a Swiss pharmaceutical company focusing on the discovery and development of anti-cancer drugs.
TCR2
TCR2 is a discovery stage pharmaceutical company that developed a unique proprietary TRuC™ platform.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Viatris
Viatris is a global pharmaceutical company formed in 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer.
Current Employees Featured
Founder
Investors List
Horizon Europe
Horizon Europe investment in Grant - Akthelia Pharmaceuticals
Technology Development Fund
Technology Development Fund investment in Grant - Akthelia Pharmaceuticals
Technology Development Fund
Technology Development Fund investment in Grant - Akthelia Pharmaceuticals
Technology Development Fund
Technology Development Fund investment in Grant - Akthelia Pharmaceuticals
Newest Events participated
Official Site Inspections
http://www.aktheliapharma.com Semrush global rank: 8.39 M Semrush visits lastest month: 539
- Host name: unalocated.63.wixsite.com
- IP address: 185.230.63.186
- Location: Ashburn United States
- Latitude: 39.018
- Longitude: -77.539
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20147
More informations about "Akthelia Pharmaceuticals"
ABOUT - Akthelia Pharma
Akthelia was founded by four eminent professors from the Karolinska Institute in Sweden and the University of Iceland. The company is focused on the discovery and development of …See details»
Akthelia Pharmaceuticals - Crunchbase Company Profile & Funding
Akthelia is an emerging pharmaceutical company focused on the discovery and development of novel antimicrobial therapeutics, which enhance the body‘s innate microbial defences.See details»
Akthelia Pharmaceuticals - BIO International Convention 2025
Akthelia is a late preclinical state biopharma company with a unique, first-in-class immunomodulatory strategy upregulating innate immunity in epithelia.See details»
Akthelia Pharmaceuticals - Devex
Learn more about Akthelia Pharmaceuticals's jobs, projects, latest news, contact information and geographical presence. Akthelia is an preclinical stage pharmaceutical company founded by …See details»
Akthelia Company Profile - Craft
Akthelia has 5 employees across 2 locations and $507.05 k in total funding,. See insights on Akthelia including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
Akthelia - Org Chart, Teams, Culture & Jobs - The Org
View Akthelia's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Akthelia Pharmaceuticals - LinkedIn
Akthelia Pharma is a late preclinical-stage immunotherapy company, with its HQ in Iceland, targeting a huge unmet opportunity to improve cancer and cell/organ transplant outcomes …See details»
Akthelia Pharmaceuticals | Leaders in Epithelial Science
Decades of research by our founding scientists, have led us to a powerful therapeutic approach that mimics and enhances the effects of natural metabolites released by microbiota to maintain …See details»
Akthelia - 2025 Company Profile & Competitors - Tracxn
Mar 22, 2025 Akthelia - Developer of small molecule therapeutic candidates for the treatment of cancer. Akthelia has 3286 competitors.See details»
Akthelia Pharmaceuticals - Products, Competitors, Financials, …
Malin Otmani April 15, 2025 According to the World Health Organization (WHO), Antimicrobial resistance (AMR) is directly responsible for an estimated 1.14 million deaths a year and …See details»
Akthelia Pharmaceuticals - Contacts, Employees, Board Members, …
Experience the new Crunchbase, powered by AI . Organization. Akthelia PharmaceuticalsSee details»
Pharmaceutical company introduced at American symposium
Apr 25, 2018 The startup company Akthelia Pharmaceuticals, founded on the basis of research conducted by scientists at the University of Iceland and the Karolinska Institute in Sweden, …See details»
PIPELINE | Akthelia Pharma
Our exciting pre-clinical stage portfolio includes our lead program - an oral prophylactic treatment for chemically induced febrile neutropenia designed to prevent life threatening infections that …See details»
Akthelia Pharmaceuticals - PitchBook
Information on valuation, funding, cap tables, investors, and executives for Akthelia Pharmaceuticals. Use the PitchBook Platform to explore the full profile.See details»
Akthelia company information, funding & investors | Dealroom.co
Dec 1, 2001 Akthelia, akthelia is focused on the discovery and development of novel antimicrobial therapeutics. Here you'll find information about their funding, investors and team.See details»
PLATFORM | Akthelia Pharma
Our lead patent-protected small molecule therapeutic candidates are aroylated phenylene diamines - small molecules that mimic but enhance the natural effects of SCFAs in vivo, via …See details»
AphaiaPharma – back to balance
Feb 20, 2025 Aphaia Pharma to Participate in Panel Discussion at the 1 st Annual BioPharma Obesity Innovation Forum in San Francisco. ZUG, Switzerland, SAN JUAN, Puerto Rico and …See details»
NEWS - Akthelia Pharma
Sep 1, 2020 RANNÍS, the Icelandic technology fund, has awarded Akthelia Pharma $330,000 for the initial development of its novel wound healing approach.See details»
Akthelia Pharmaceuticals and the University of Iceland Secure a …
Apr 17, 2023 The project seeks to address antimicrobial resistance (AMR), a major global health threat identified by the World Health Organization (WHO) as one of the top 10 health …See details»
CLINICAL FOCUS - Akthelia Pharma
Akthelia is developing small molecule therapeutics that immunomodulate epithelial surfaces to counteract the pathogenesis of these diseases. Our exciting pre-clinical stage portfolio …See details»